Company news
Rapport Therapeutics, Inc. news in 2024
Rapport Therapeutics, Inc.'s news releases, calls and decks from 2024, newest first.
Rapport Therapeutics Presents Data Demonstrating Consistent Association Between Decreases in RNS Measured Long Episodes and Meaningful Reductions in Clinical Seizures
December 5, 2024
Rapport Therapeutics to Present Data at American Epilepsy Society Annual Meeting
November 13, 2024
Rapport Therapeutics Reports Third Quarter Financials and Provides Business Update
November 6, 2024
Rapport Therapeutics to Present at Stifel Healthcare Conference and Jefferies London Healthcare Conference in November
November 3, 2024
Rapport Therapeutics to Present at Upcoming Epilepsy Medical Conferences
September 4, 2024
Rapport Therapeutics to Present at 22nd Annual Morgan Stanley Global Healthcare Conference and TD Cowen’s 4th Annual Novel Mechanisms in Neuropsychiatry Summit
August 28, 2024
Rapport Therapeutics Reports Second Quarter Financials and Provides Business Update
August 7, 2024
Rapport Therapeutics to Present Data for TARPγ8 AMPAR Negative Modulator at IASP 2024 World Congress on Pain
July 28, 2024
Rapport Therapeutics Announces Closing of $174 Million Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares and Concurrent Private Placement
June 11, 2024
Decks in 2024
- Epilepsy Foundation Pipeline Conference 2024
Conference · 8 slides · Sep 25, 2024
- Investor Presentation (May 2024)
Investor deck · 40 slides · May 2024